Furthermore, interfering with PMEPA1 after knocking down METTL16 inhibited proliferation of bladder tumor cells, while increased the rate of cisplatin-induction apoptosis, the sensitivity of cells to cisplatin and the expression of apoptosis related protein. This evidence concerns the gene METTL16 and urinary bladder neoplasm.